Bacterial Co-infection in Hospitalized Children with Mycoplasma pneumoniae Pneumonia

Qing Song1, Bao-Ping Xu, Kun-Ling Shen

  • 1Aerospace Center Hospital and *Beijing Childrens Hospital, Capital Medical University, China. Correspondence to: Dr KL Shen, Beijing Children's Hospital, Capital Medical University, Beijing, 56 NanlishiRd, XichengDistrict, China. wlj7008@126.com.

Indian Pediatrics
|October 25, 2016
PubMed
Abstract

Insights

Bacterial co-infections are uncommon in children with Mycoplasma pneumoniae pneumonia, but Streptococcus pneumoniae is the most frequent pathogen. This finding is crucial for understanding pediatric respiratory infections.

Area of Science:

  • Pediatric Infectious Diseases
  • Respiratory Medicine
  • Microbiology

Background:

  • Mycoplasma pneumoniae pneumonia is a common childhood respiratory infection.
  • Bacterial co-infections can complicate the clinical course and management of pneumonia.
  • Understanding the spectrum of co-infecting pathogens is essential for effective treatment strategies.

Purpose of the Study:

  • To determine the incidence of bacterial co-infections in children hospitalized with Mycoplasma pneumoniae pneumonia.
  • To identify the most common bacterial pathogens involved in these co-infections.
  • To analyze the clinical features and healthcare costs associated with bacterial co-infections.

Main Methods:

  • A retrospective, descriptive study was conducted.
  • Data from 8612 children admitted to a tertiary-care hospital in Beijing, China, between June 2006 and June 2014 were analyzed.
  • Children were categorized into pure M. pneumoniae infection and mixed bacterial infection groups based on etiological testing.

Main Results:

  • Bacterial co-infection was identified in 173 (2%) of the children studied.
  • Streptococcus pneumoniae was the most frequently identified bacterial pathogen, accounting for 56.2% of co-infections.
  • Differences in clinical features and hospital expenses between the groups were analyzed.

Conclusions:

  • Streptococcus pneumoniae is the predominant bacterial pathogen co-infecting children with Mycoplasma pneumoniae pneumonia.
  • The findings highlight the importance of considering specific bacterial co-infections in the management of pediatric pneumonia.
  • Further research may elucidate the clinical impact and optimal therapeutic approaches for these mixed infections.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
992
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.8K
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
5.2K